Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Immunotherapy drug found to be effective in patients with advanced Merkel cell carcinoma

A multi-center phase II clinical trial investigating pembrolizumab as a first-line and programmed cell death-1 therapy in patients with advanced Merkel cell carcinoma reports lasting tumor control, generally manageable side effects and improved overall survival.

8 Feb 2019

New prostate cancer prediction tool has unmatched accuracy

A team of researchers from the Icahn School of Medicine at Mount Sinai and Keck School of Medicine at the University of Southern California have developed a novel machine-learning framework that distinguishes between low- and high-risk prostate cancer with more precision than ever before.

7 Feb 2019

Physicians more likely to prescribe drugs of manufacturers who paid them money

In a study published in The Oncologist, physicians treating certain cancers who consistently received payments from a cancer drug's manufacturer were more likely to prescribe that drug over alternative treatments.

6 Feb 2019

Simulation model to find the most optimal cancer treatment

In ten years, computers will be able to propose the most suitable cancer treatment for you. The idea is to simulate how all possible combinations of existing cancer treatments will work on your particular tumor.

6 Feb 2019

Study: Maternal age, body mass index, race affect hormone concentrations in pregnancy

Hormone concentrations during early fetal development -- that may affect the child's development and increase the mother's risk for breast and ovarian cancer years later -- are significantly affected by maternal age, body mass index and race rather than lifestyle, according to a Rutgers study.

5 Feb 2019

New study shows that larger prostate actually impedes tumor growth

For men older than about 60, an enlarged prostate means feeling the urge to make a pit stop way too often throughout the day.

5 Feb 2019

Experts characterize normal electrical activity in prostate cancer cells in real time

Experts from the Universities of Bath and Seville have carried out a series of experiments with which, for the first time, they have been able to characterize the normal electrical activity in PC-3 prostate cancer cells in real time, with a resulting low-frequency electrical pattern between 0.1 and 10 Hertz.

5 Feb 2019

Study shows promise for future prostate cancer treatment

A new 'seek-and-destroy' gene therapeutic system could have the potential to treat prostate cancer in the future, after it halted the majority of tumors in laboratory models at the University of Strathclyde and the Beatson Institute.

4 Feb 2019

Expediting HPLC Method Development in Pharmaceutical Analysis

In this interview, Michael Dong discusses stability-indicating methods such as UHPLC, in pharmaceutical analysis. At Pittcon, Michael will introduce a 3-pronged template approach to HPLC method development.

From Pittcon 30 Jan 2019

Community hospitals link arms with prestigious facilities to raise their profiles

After seven years of a vigorous fight, Jim Hart worried he was running out of options. Diagnosed with prostate cancer at age 60, Hart had undergone virtually every treatment — surgery, radiation and hormones — to eradicate it. But a blood test showed that his level of prostate-specific antigen, which should have been undetectable, kept rising ominously. And doctors couldn’t determine where the residual cancer was lurking.

29 Jan 2019

RNA-induced gene fusion can occur in mammalian cells, reveals study

A fusion gene is a new gene made by joining parts of two different genes. The current thought is that fusion genes can happen in cells with unstable genome when part of the DNA from one chromosome moves to another chromosome.

29 Jan 2019

Nine early career scientists named 2019 recipients of the Damon Runyon-Rachleff Innovation Award

The Damon Runyon Cancer Research Foundation announced that nine scientists with novel approaches to fighting cancer have been named 2019 recipients of the Damon Runyon-Rachleff Innovation Award.

24 Jan 2019

Norwegian scientists discover new small molecule drug to treat prostate cancer

Professor Fahri Saatcioglu at University of Oslo's Department of Biosciences (IBV) heads a research group investigating how androgens - male sex hormones - affect the risk of being affected by prostate cancer.

24 Jan 2019

Researchers use modified type of flu virus to develop new therapies for prostate cancer

Scientists from Queen Mary University of London have received a grant from leading men's health charity, Prostate Cancer UK, as London continues to lead the way in advanced prostate cancer research.

23 Jan 2019

PSA screening reduces prostate cancer deaths by 30%

PSA-screening cuts deaths from prostate cancer by some 30%. This is shown by research based on data on 20,000 men monitored for more than two decades. The men's initially measured PSA level proved highly significant as a predictor of future cancer risk.

22 Jan 2019

UIC researchers receive $1.7 million NCI grant to study Southeast Asian fruit

For generations, traditional healers in Southeast Asia have used the mangosteen fruit to treat skin infections, wounds, dysentery and urinary tract infections.

18 Jan 2019

Rutgers study finds gene responsible for spread of prostate cancer

A Rutgers study has found that a specific gene in cancerous prostate tumors indicates when patients are at high-risk for the cancer to spread, suggesting that targeting this gene can help patients live longer.

17 Jan 2019

Researchers find how GREB1 gene promotes resistance to prostate cancer treatments

Researchers have discovered how a gene involved in regulating hormone receptors may contribute to drug resistance in some prostate cancer patients.

16 Jan 2019

Molecular hallmarks of tumor hypoxia across 19 cancer types discovered

Unlike healthy tissues, tumors thrive in low-oxygen environments, often acquiring the ability to resist treatment and spread to other sites in the body. Despite being a well-known cause of therapy resistance and metastasis, the impact of low oxygen, known as hypoxia, on tumor cells is poorly understood.

14 Jan 2019

Scientists discover mutational signatures of tumor hypoxia

Researchers have discovered mutational signatures of tumor hypoxia in 19 cancer types that could be used to identify patients who need higher treatment doses.

14 Jan 2019